摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[2-Acetyloxy-4-[(3,4-diacetyloxyphenyl)methyl]phenyl] acetate | 1046269-02-6

中文名称
——
中文别名
——
英文名称
[2-Acetyloxy-4-[(3,4-diacetyloxyphenyl)methyl]phenyl] acetate
英文别名
——
[2-Acetyloxy-4-[(3,4-diacetyloxyphenyl)methyl]phenyl] acetate化学式
CAS
1046269-02-6
化学式
C21H20O8
mdl
——
分子量
400.385
InChiKey
WETPKOORWZOSER-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    29
  • 可旋转键数:
    10
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.24
  • 拓扑面积:
    105
  • 氢给体数:
    0
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    4-[(3,4-二甲氧基苯基)甲基]-1,2-二甲氧基苯溶剂黄146三溴化硼 作用下, 以 二氯甲烷 为溶剂, 以91%的产率得到[2-Acetyloxy-4-[(3,4-diacetyloxyphenyl)methyl]phenyl] acetate
    参考文献:
    名称:
    O-Acetylation: Synthesis of Acetylated Phenols from Aryl-Methyl Ethers Over Boron Alkoxides
    摘要:
    利用硼化学将一种新的乙酰化程序应用于 13 种芳基甲基醚。在这一过程中,芳基甲基醚的脱甲基化和所得苯酚的乙酰化被合并为一个过程,以缩短阶段数量并实现简易纯化。通过这种方法,从它们的甲氧基衍生物合成了 11 种已知的含/不含溴和两种新的[双(3,4-二乙酰氧基苯基)甲酮和 5,5'-亚甲基双(1,2-二乙酰氧基-3,4-二溴苯)(一种天然溴酚的乙酰化衍生物)]乙酰化炔化合物。从天然溴苯酚的甲醚中制备出乙酰化天然溴苯酚,证明了该方法的有效性。通过水解乙酰化天然溴苯酚可以得到苯酚形式。因此,该方法在酚类化合物天然产物化学方面的优势得到了证实。
    DOI:
    10.3184/174751912x13324176277811
点击查看最新优质反应信息

文献信息

  • [EN] COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE<br/>[FR] COMPOSES, COMPOSITIONS ET PROCEDES DE TRAITEMENT DE MALADIES AMYLOIDES ET DE SYNUCLEINOPATHIES, NOTAMMENT DE LA MALADIE D'ALZHEIMER, DU DIABETE DE TYPE 2 ET DE LA MALADIE DE PARKINSON
    申请人:PROTEOTECH INC
    公开号:WO2003101927A1
    公开(公告)日:2003-12-11
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aß amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinophathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药用可接受酯,它们的合成,含有它们的药物组合物,以及它们在治疗淀粉样疾病,特别是Aß淀粉样病变,如阿尔茨海默病中观察到的,IAPP淀粉样病变,如2型糖尿病中观察到的,以及α-突触核病,如帕金森病中观察到的,以及用于制造用于此类治疗的药物。
  • Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis
    申请人:Snow D. Alan
    公开号:US20070225362A1
    公开(公告)日:2007-09-27
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, AA/SAA amyloidosis, such as observed in systemic AA amyloidosis and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双羟基和三羟基芳基化合物及其甲氧基二氧杂环化物和药学上可接受的酯类,它们的合成,含有它们的制药组合物,以及它们在治疗淀粉样疾病,特别是阿尔茨海默病中观察到的Aβ淀粉样变性,IAPP淀粉样变性,例如在2型糖尿病中观察到的AA / SAA淀粉样变性,以及突触蛋白病,例如在帕金森病中观察到的应用,以及用于制造这种治疗药物。
  • Compounds, compositions and methods for the treatment of synucleinopathies
    申请人:Esposito Luke
    公开号:US20070276034A1
    公开(公告)日:2007-11-29
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of synucleinopathies, such as Parkinson's disease, and the manufacture of medicaments for such treatment.
    双-和三-二羟基芳基化合物及其亚甲二氧基类似物和药学上可接受的酯,它们的合成,含有它们的制药组合物,以及它们在治疗突触核病,如帕金森病中的应用和制造用于这种治疗的药物。
  • COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
    申请人:Snow Alan D.
    公开号:US20090069432A1
    公开(公告)日:2009-03-12
    Bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs and pharmaceutically acceptable esters, their synthesis, pharmaceutical compositions containing them, and their use in the treatment of amyloid diseases, especially Aβ amyloidosis, such as observed in Alzheimer's disease, IAPP amyloidosis, such as observed in type 2 diabetes, and synucleinopathies, such as observed in Parkinson's disease, and the manufacture of medicaments for such treatment.
    双-和三-二羟基芳基化合物及其二氧化甲基类似物和药学上可接受的酯,它们的合成,含有它们的制药组合物,以及它们在治疗淀粉样疾病中的应用,尤其是Aβ淀粉样蛋白病,如阿尔茨海默病,IAPP淀粉样蛋白病,如2型糖尿病,以及突触核病,如帕金森病,和用于制造这种治疗药物。
  • Compounds, compositions and methods for the treatment of inflammatory diseases
    申请人:Sanders J. Virginia
    公开号:US20070208087A1
    公开(公告)日:2007-09-06
    The use of a composition comprising a compound: where R is a C 1 -C 10 alkylene group, in which, when the number of carbon atoms is at least 2, there are optionally 1 or 2 non-adjacent double bonds; 1 to 3 non-adjacent methylene groups are optionally replaced by NR 1 (where R 1 is H, alkyl, or acyl), O, or S; and 1 or 2 methylene groups are optionally replaced by a carbonyl or hydroxymethylene group for the preparation of a medicament or a pharmaceutical for the treatment of inflammatory diseases.
    使用含有化合物的组合物:其中R是C1-C10烷基基团,当碳原子数至少为2时,可以选则1或2个非相邻的双键;1到3个非相邻的亚甲基团可以被NR1(其中R1为H,烷基或酰基)、O或S替换;并且1或2个亚甲基团可以被羰基或羟甲基基团替换,以制备用于治疗炎症性疾病的药物或制剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐